e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Phenotypes and comorbidities of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The risk of hyperkalemia in COPD and asthma patients
J. Mäenpää (Gothenburg, Sweden), U. Emerath (Gothenburg, Sweden), S. Sultana (Cambridge, United Kingdom), M. Olsson (Gothenburg, Sweden), M. Carlsson (Gothenburg, Sweden)
Source:
International Congress 2019 – Phenotypes and comorbidities of airway diseases
Session:
Phenotypes and comorbidities of airway diseases
Session type:
Thematic Poster
Number:
4334
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Mäenpää (Gothenburg, Sweden), U. Emerath (Gothenburg, Sweden), S. Sultana (Cambridge, United Kingdom), M. Olsson (Gothenburg, Sweden), M. Carlsson (Gothenburg, Sweden). The risk of hyperkalemia in COPD and asthma patients. 4334
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021
Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011
COPD mortality after severe exacerbations
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020
Management of patients with asthma or COPD and cardiovascular disease: risks
versus
benefits
Source: Eur Respir Monogr 2020; 88: 66-81
Year: 2020
Markers of T2-inflammation in patients with severe asthma and concomitant COPD
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Risk factors for mortality in patients with COPD exacerbation
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations
Source: Eur Respir J, 53 (4) 1900147; 10.1183/13993003.00147-2019
Year: 2019
The effect of smoking on exacerbation risk in eosinophilic patients with COPD
Source: Eur Respir J, 50 (6) 1702086; 10.1183/13993003.02086-2017
Year: 2017
The effect of smoking on exacerbation risk in eosinophilic patients with COPD
Source: Eur Respir J, 50 (6) 1701820; 10.1183/13993003.01820-2017
Year: 2017
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
The impact of airway infection on cardiovascular risk during COPD exacerbations
Source: Annual Congress 2012 - Acute exacerbation in COPD
Year: 2012
Noncompliance factors in Russian asthma and COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 274s
Year: 2005
Budesonide is not associated with increased risk of pneumonia in COPD patients
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept